Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Johnson & Johnson (NYSE: JNJ) wins key CHMP backing for nipocalimab in gMG—could this reshape Europe’s autoimmune treatment market?
Johnson & Johnson’s nipocalimab wins CHMP backing for gMG, setting stage for potential EU approval in adults and adolescents. Learn what this means for patients.
Island Pharmaceuticals stock climbs as FDA clears path for Galidesivir fast-track review
Island Pharmaceuticals (ASX: ILA) stock rises as FDA fast-tracks Galidesivir under the Animal Rule, with survival data, PRV potential, and stockpile contracts in focus.
89bio stock soars 85% as Roche seals $3.5bn takeover—What’s behind the surge and what’s next?
Roche is buying 89bio for up to $3.5B to add Phase 3 MASH drug pegozafermin. Find out what the CVR means and how investors should read the deal today.
Formation Bio hires ex-Pfizer and BenevolentAI leaders to supercharge its AI-driven drug development model
Formation Bio bolsters its leadership team with top biotech and pharma veterans to fast-track its AI-driven drug development model.
Why investors are watching Neurizon Therapeutics (ASX: NUZ) ahead of FDA clearance for NUZ-001
Neurizon Therapeutics (ASX: NUZ) secures A$5m to fund ALS trial entry. Can NUZ-001 succeed in the HEALEY ALS Platform Trial and change the biotech landscape?
Thryv Therapeutics secures FDA IND clearance to launch first potential drug for Long QT syndrome
Thryv Therapeutics gains FDA IND clearance for THRV-1268 in Long QT Syndrome, aiming to pioneer the first disease-modifying therapy for this rare disorder.
GLP-1 receptor agonists show promise in cutting death and heart risk in psoriasis patients
Discover how GLP-1 drugs may slash death and heart risks in psoriasis patients, reshaping care strategies beyond skin treatment.
Can high-dose GLP-1 therapies reshape obesity care—or are we nearing the biological ceiling?
Are high-dose GLP-1 drugs like Wegovy 7.2mg and Zepbound 15mg unlocking better weight loss—or just more side effects? Here’s what the latest data suggests.
Hemogenyx Pharmaceuticals stock jumps after third patient in CAR-T AML trial shows safety and early efficacy
Hemogenyx Pharmaceuticals (LSE: HEMO) stock jumps 24% after third patient treated in CAR-T AML trial shows safety and early efficacy.
AstraZeneca’s Fasenra misses primary endpoint in COPD trial but keeps investor confidence alive
AstraZeneca’s Fasenra failed to hit its COPD trial endpoint, but stock rose 0.44% as investors bet on pipeline strength and respiratory growth.